PURE Bioscience, Inc. reported earnings results for the full year ended July 31, 2021. For the full year, the company reported revenue was USD 3.93 million compared to USD 6.92 million a year ago. Net loss was USD 2.32 million compared to net income of USD 0.004 million a year ago. Basic loss per share from continuing operations was USD 0.03. Diluted loss per share from continuing operations was USD 0.03.